Delirium is a common complication of critically ill patients and is often associated with metabolic disorders. One of the most frequent metabolic disorders in intensive care unit (ICU) patients is hyperglycaemia. The aim of this retrospective study of 196 adult ICU patients was to determine if there is an association between hyperactive delirium and blood glucose levels in ICU patients. Hyperactive delirium was diagnosed using the delirium detection score. Blood glucose levels were monitored by blood gas analysis every 4 h. Hyperactive delirium was detected in 55 (28%) patients. Delirious patients showed significantly higher blood glucose levels than non-delirious patients Higher overall complication rates, length of ventilation, ICU stay and mortality rates were seen in the delirium group. In a multivariate analysis, glucose level, alcohol abuse, APACHE II score, complication by hospital-acquired pneumonia and a diagnosis of polytrauma on-admission all significantly influenced the appearance of delirium.
Introduction
Delirium is a severe dysfunction of the brain, characterized by acute onset of confusion, inattention, disorganized thinking and a fluctuating course of mental status changes. It is a common post-operative complication in hospitalized patients, especially elderly and demented patients. 1 -4 Up to 20% of hospitalized patients aged > 65 years are affected by delirium; in an intensive care setting there are reports of up to 80% prevalence. 5, 6 The probability of developing delirium is related to age and illness severity. 5, 7 Patients requiring intensive care are likely to be subject to several risk factors, such as drug interactions, hypoxaemia, hypotension, brain injury, stroke, infections, 8 acute metabolic or endocrine disorders, intoxication, fever, analgesia withdrawal or inadequate analgesia and sedation. 9 Pathophysiologically delirium is based on an imbalance of neurotransmitters in the central nervous system, as well as in the sympathetic and parasympathetic nervous systems. 9 -11 An imbalance in the cholinergic and dopaminergic neurotransmitter systems is most commonly implicated in causing delirium. 10 Significant perturbations of the noradrenergic neuronal system and a change in corticotropin releasing hormone have been identified during acute alcohol Hyperactive delirium and blood glucose control withdrawal, 11 and salivary cortisol concentrations are elevated during alcohol withdrawal. 12 Disturbances of the hypothalamic-pituitary-adrenal system have also been found in delirious patients. 13 Once delirium has developed, it is associated with poor cognitive outcome, dementia 14, 15 and increased costs. 16 Delirium is an independent predictor of mortality 17 and prolonged intensive care unit (ICU) and hospital stay. 5, 18 For early diagnosis of delirium, monitoring is required as part of routine daily practice. 6, 9, 19 Hyperactive and hypoactive forms of delirium are reported to occur in 15% versus 25% of patients, respectively, however in most cases mixed forms are observed. 20 Hypoactive states are difficult to diagnose without training. 21 The delirium detection score (DDS) is a score designed to diagnose hyperactive states and can be used as an option for nursing staff to treat the patient in a timely manner using a symptom-oriented approach. 9, 22 To the best of our knowledge, an association between elevated glucose concentrations and delirium has not yet been extensively investigated in ICU patients. There is evidence, however, that intra-and postoperative hyperglycaemia, particularly during cardiac surgery, is an independent risk factor for complications, including delirium. 23 -26 Hyperglycaemia is a common feature of the critically ill patient and has been associated with increased mortality. 27 The severity of stress-induced hyperglycaemia and insulin resistance in critically ill patients reflects the risk of death. Maintaining normoglycaemia with insulin therapy improves survival and reduces morbidity in surgical ICU patients, as shown by large randomized controlled studies. 27, 28 In medical ICU patients, intensive insulin therapy to maintain blood glucose between 80 and 110 mg/dl has been shown significantly to reduce morbidity. 28 The aim of this retrospective analysis was to find out if there is an association between ICU delirium and blood glucose levels (the primary outcome measure), and also if there is an association between ICU delirium and clinical outcomes, such as overall complication rates, duration of ICU stay and mortality (the secondary outcome measures). 
Patients and methods

PATIENTS
GROUP ASSIGNMENT
Delirium was monitored using the DDS, which is a validated score to assess the severity of delirium in patients in the ICU (Table 1 ). 9 The DDS was performed three times daily by the nurse responsible and was documented in the ICU patient data management system (PDMS).
Patients were assigned to the following groups: hyperactive delirium (DDS > 7); nonhyperactive delirium (DDS ≤ 7); this was based on the work of Otter et al., 9 who showed there to be a high sensitivity and specifity for delirium if the DDS was > 7. Any patient who had one positive screening was considered to have delirium and was included in the delirium group.
A Heymann, M Sander, D Krahne et al. Hyperactive delirium and blood glucose control
BLOOD GLUCOSE MONITORING
Blood glucose levels were routinely monitored by blood gas analysis (ABL 700 Series (Radiometer Copenhagen, Copenhagen, Denmark) every 4 h in the first 3 days in cases of instability (sepsis, shock, organ failure and diabetes). After 3 days, we monitored blood glucose levels every 8 h if the patient was in a stable condition. In cases of instability or diabetes, we continued the monitoring every 4 h. The aim was to maintain blood glucose between 80 and 130 mg/dl. Tighter glucose control has been shown to lead to severe problems with electrolyte disturbances and hypoglycaemia, and even with the risk of increased morbidity and mortality 29 . In our investigation, blood glucose levels ≥ 130 mg/dl were defined as hyperglycaemia.
Insulin dosage requirements were documented in the PDMS.
RECORDS FOR THE PDMS
Scores concerning consciousness (GCS and RASS) were recorded three times daily by the nurse responsible and documented in the ICU PDMS system. Acute Physiology and Chronic Health Evaluation II (APACHE II), Sequential Organ Failure Assessment (SOFA) and Therapeutic Intervention Scoring System (TISS) scores were recorded daily. 30 Alcohol use disorder was diagnosed if patients had either a diagnosis of alcohol dependence or harmful use (International Classification of Diseases 10 [ICD10] classification). Infection complications were categorized into hospital-associated pneumonia (HAP), ventilator-associated pneumonia (VAP), 'other infections' or sepsis with multiple organ dysfunction syndrome (MODS); microbial screening occurs routinely on admission to our ICUs (nose, 31, 32 Diagnosis of pneumonia was made according to recognized guidelines for the diagnosis of HAP. 32 Sepsis was diagnosed according to the guidelines of the Surviving Sepsis Campaign Management Committee. 33 A MODS was diagnosed if more than one organ failure occurred, e.g. respiratory and acute renal failure.
Other complications that occurred in the group were anastomosis leakage (requiring surgical revision), cardiovascular complications such as heart attack (diagnosis was made based on further investigations such as troponin and electrocardiography), heart failure (echocardiographic diagnosis), bleeding from the operation field (requiring surgical revision) and deep vein thrombosis (ultrasonographic diagnosis). Times of mechanical ventilation and ICU stay were also documented in the PDMS.
STATISTICAL ANALYSIS
All numerical calculations were carried out with SPSS ® for Windows ® , version 11.5.1 (SPSS Inc., Chicago, IL, USA). Data were expressed as mean ± SD for continuous variables or median (interquartile range) for categorical characteristics. In the case of continuous variables, the Mann-Whitney Utest was used for univariate intergroup differences between patients with and without hyperactive delirium. Categorical variables were examined with the χ 2 test. Multivariate logistic regression was used to investigate the association between hyperactive delirium and blood glucose level, adjusted by other clinical risk factors of interest. Multivariate proportional hazard Cox regression, with delirium as the event and the time to hyperactive delirium as the survival time, was applied to analyse the relationship between time to hyperactive delirium and clinical risk factors of interest. Owing to the great number of risk factors in question, a feature preselection in two steps was accomplished: first based on clinical reasoning and second taking those features into the multivariate analysis with P < 0.1 in the corresponding univariate tests. Receiver operating characteristics (ROC) analysis evaluated predictive ability of the multivariate logistic regression model. Pvalues < 0.05 were considered to be statistically significant.
Results
A total of 374 patients admitted either to the ICU or IMCU were screened for delirium of which 41 were excluded according to the exclusion criteria and a further 137 patients were excluded due to missing data. Data Hyperactive delirium was diagnosed in 55 (28%) patients. There was no significant difference in age or gender between hyperactive delirious and non-hyperactive delirious patients (Table 2) . With respect to 'accompanying illnesses' there was a significant difference between groups regarding arterial hypertension (P < 0.001) and alcohol/drug abuse (P = 0.001), but not for other diagnoses (Table 2 ). In terms of the admission diagnoses, only polytrauma was significantly correlated with hyperactive delirium (P = 0.045) ( Table 2) .
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Surgery had been carried out on 95% of patients. Antibiotic therapy was given to 15% of the hyperactive delirium patients and to 39% of the non-hyperactive delirium patients. When all DDS measurements were taken into account, the hyperactive delirious patients had positive DDS measurements in 75% (range 67% -83%) of the performed measurements, 18 times (range 5 -33 times) per patient in absolute figures.
The diagnosis of hyperactive delirium was made 4.6 + 3.0 days after admission to the ICU or IMCU and the duration of delirium was 3.7 + 0.6 days. Therapy was symptomoriented with neuroleptics (haloperidol), benzodiazepines (lorazepam, diazepam) and central alpha-2 agonists (clonidine); 16 (29%) patients did not receive any therapy. There was no significant correlation between the duration of hyperactive delirium and therapy.
In the hyperactive delirium group, blood glucose levels ≥ 130 mg/dl were significantly more frequent than in the non-hyperactive delirium group (P = 0.023) (Fig. 1 ). In the hyperactive delirium patients with blood glucose concentrations ≥ 130 mg/dl, levels were already significantly (P = 0.012) elevated in the 5-day period before hyperactive delirium was diagnosed compared with the delirium patients whose blood glucose levels were < 130 mg/dl (Fig. 2) . Insulin requirements differed significantly between hyperactive delirious and nonhyperactive delirious patients (P = 0.036) ( Table 3 ). There was no statistical difference 
FIGURE 2:
Blood glucose levels (mean ± SD) in patients during the period 5 days before and 5 days after diagnosis of hyperactive delirium (delirium detection score > 7; day 0, first diagnosis of delirium). In the hyperactive delirium patients with blood glucose ≥ 130 mg/dl, levels were already significantly (P = 0.012) elevated in the 5days before hyperactive delirium was diagnosed compared with the delirium patients whose blood glucose levels were < 130 mg/dl 
TABLE 3: Complications, mortality, assessment scores, insulin requirements and duration of treatment in patients admitted either to the anaesthesiology intensive care unit or to the intermediate care unit and screened for the presence or absence of hyperactive delirium a Hyperactive delirium and blood glucose control
Time of mechanical ventilation and time of ICU or IMCU stay were prolonged in the hyperactive delirium group (P = 0.01 and P < 0.001, respectively) ( Table 3 ). Mortality in the hyperactive delirium group was elevated compared with the non-hyperactive delirium group (22% versus 5.7%, P = 0.02) ( Table 3) . Univariate analysis showed a significantly greater incidence of hyperactive delirium in patients with blood sugar levels ≥ 130 mg/dl (P = 0.023) ( Table 3 ). Significantly higher insulin dosage (P = 0.036) was also seen in the hyperactive delirium patients ( Table 3) .
We performed a multivariate logistic regression analysis to evaluate associations between hyperglycaemia, illness severity, accompanying diseases, admission diagnoses, complications, age and hyperactive delirium. A significant influence was found of hyperglycaemia (P = 0.009), alcohol abuse (P = 0.006) APACHE II, SOFA, HAP/VAP, and polytrauma (each P = 0.000)
Regression
Standard Odds ratio Parameter coefficient error P-value (95% confidence limits) (Table 4 ). For a more detailed analysis of the relation between hyperglycaemia and hyperactive delirium we performed a proportional hazard Cox regression analysis with time-varying covariates, taking hyperactive delirium as the event and the time to hyperactive delirium as survival time ( Table 5 ). The results complement the findings of the multivariate logistic regression and demonstrate again that blood glucose level is an independent risk factor. Moreover, APACHE II (P = 0.000), HAP/VAP (P = 0.005), alcohol abuse (P = 0.015) and polytrauma (P = 0.005) were also shown as significant, supporting the results of the multivariate logistic regression analysis.
Patients with blood glucose concentrations ≥ 130 mg/dl were shown in the Kaplan-Meier curve to have earlier and more frequent hyperactive delirium than patients with blood glucose concentrations < 130 mg/dl (P < 0.001) ( Fig. 3 ). The positive predictive ability of the multivariate logistic regression model tested by ROC analysis showed an area under the curve of 0.911 (95% confidence limits 0.867, 0.954) ( Fig. 4) .
Discussion
We were able to verify the hypothesis that elevated blood glucose levels are associated with a higher incidence of hyperactive delirium. To the best of our knowledge, the correlation between abnormal glucose concentrations and incidence of hyperactive delirium has not previously been examined in ICU patients. The incidence of hyperactive delirium in our study was 28% and is comparable with previous studies in which A Heymann, M Sander, D Krahne et al. Hyperactive delirium and blood glucose control incidences of 9% -40% have been reported in surgical or surgical/medical ICU patients. 34 -36 Ely et al. 5 have even reported a hyperactive delirium incidence as high as 80%. We were able to reproduce the result of other authors with respect to the association of hyperactive delirium with a raised APACHE II score, 18 increased complications, a prolongation of ventilation and stay in the ICU 5 and a higher mortality. 37 All of this underlines again the importance of preventing hyperactive delirium or at least the value of early diagnosis and treatment.
In our study, the DDS was used to diagnose hyperactive delirium. The DDS is a validated score to assess severity of hyperactive delirium in the ICU. 9 Other investigators frequently use the Confusion Assessment Method (CAM-ICU) for diagnosis of hypo-and hyperactive delirium in the ICU; 6, 15 however, it is difficult to perform this without training 21 and, therefore, it is not possible to evaluate it retrospectively. 38, 39 This is due to the fact that we cannot distinguish between trained and untrained users in a retrospective design. The DDS differentiates several hyperactive delirium aspects very well and is used for a direct symptom-oriented therapy in our ICU. Consequently, a limitation of our study was that we might have missed the majority of hypoactive forms of delirium. Almost 30% of the delirious patients had a RASS ≤ -1, indicating, probably, a mixture of hypo-and hyperactive delirium.
The influence of abnormal blood glucose concentrations on morbidity and mortality of critically ill patients is undisputed. 23, 40 The severity of stress-induced hyperglycaemia and insulin resistance in critically ill patients reflects the risk of death. Maintaining normoglycaemia with insulin therapy improves survival and reduces morbidity in surgical ICU patients, as shown by large randomized controlled studies. 27, 41 In medical ICU patients, intensive insulin therapy aimed at maintaining blood glucose within a range of 80 -110 mg/dl significantly reduced morbidity. 23, 28 There is also evidence that intra-and postoperative hyperglycaemia is an independent risk factor for complications, including delirium, after cardiothoracic surgery. 25, 26 Diabetes mellitus has been identified as a significant independent predictor for several post-operative outcome variables after cardiac surgery, and is associated with higher overall post-operative morbidity, increased incidence of delirium and prolonged hospital stay. 42 In our analysis, diabetes had no influence on the onset of hyperactive delirium.
We observed that hyperactive delirium was associated with elevated blood glucose levels, elevated APACHE II scores, alcohol abuse, polytrauma and HAP/VAP. Despite a tendency towards a correlation between APACHE II scores and glucose concentrations, the association was not statistically significant. We suggested, therefore, that hyperglycaemia is an independent risk factor for the development of hyperactive delirium. This hypothesis was supported by the fact that delirium patients with blood glucose concentrations ≥ 130 mg/dl already showed elevated blood sugar levels before hyperactive delirium was diagnosed.
The limitations of our study include its retrospective design and an under-reporting of hypoactive deliria. We did not examine logical thinking and the ability to concentrate with the DDS. For a better examination of cognitive functions in further studies, the CAM-ICU should be used in a prospective setting. The fact that almost 30% of the hyperactive delirious patients did not receive therapy may reflect the fact that In conclusion, we found a strong association between hyperglycaemia and the development of hyperactive delirium. Further prospective evaluations with larger numbers of patients are needed to evaluate the independent influence of hyperglycaemia on the development of hyperactive delirium and abnormal glucose values.
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